CUSIP 61559X104CLASS A ORDMLTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
128 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bvf Inc/Il | 19.75M | $260.32M | 0 | Held |
| 2 | Deep Track Capital, LP | 4.61M | $60.76M | +4.61M | New |
| 3 | Cormorant Asset Management, LP | 4.36M | $57.40M | +2.36M | Added |
| 4 | D. E. Shaw & Co., Inc. | 2.48M | $32.70M |
| +2.48M |
| New |
| 5 | Janus Henderson Group PLC | 2.10M | $27.66M | +2.08M | Added |
| 6 | Logos Global Management LP | 1.75M | $23.07M | +1.75M | New |
| 7 | Jane Street Group, LLC | 1.68M | $22.17M | +1.66M | Added |
| 8 | Balyasny Asset Management L.P. | 1.57M | $20.71M | −128.2K | Reduced |
| 9 | Morgan Stanley | 1.04M | $13.77M | +787.9K | Added |
| 10 | Vivo Capital, LLC | 1.00M | $13.18M | +1.00M | New |
See every fund holding Moonlake Immunotherapeutics, with full quarter-over-quarter share changes.
Unlock all holders